Abstract CT175: Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of SHR-A1811 in HER2-expressing/mutated Advanced Solid Tumors: A Global Phase 1, Multi-Center, First-in-human Study
Cancer Research（2023）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined